ClosedOpportunity HRSA-22-145

Hereditary Hemorrhagic Telangiectasia (HHT) Center

Health Resources and Services Administration · Department of Health and Human Services

At a glance

Hereditary Hemorrhagic Telangiectasia (HHT) Center is a closed federal cooperative agreement opportunity from the Health Resources and Services Administration (Department of Health and Human Services). The application deadline was May 17, 2022. Individual awards are listed as up to $2M, with about 1 award expected and $2M in total estimated funding. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 6 more. Cost sharing is not required. It is funded under Assistance Listing 93.110 (Special Projects of Regional and National Significance).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Mar 18, 2022Posted
May 17, 2022Application deadline

Posted: Mar 18, 2022
Close date: May 17, 2022
Award floor: Not specified
Award ceiling: $2,000,000
Est. total funding: $2,000,000
Expected awards: 1
Cost sharing: Not required
Funding instrument: Cooperative Agreement
Opportunity category: Discretionary

Who can apply

State governments
County governments
City or township governments
Special district governments
Independent school districts
Federally recognized tribal governments
Native American tribal organizations
501(c)(3) nonprofits
For-profit organizations (not small businesses)
Small businesses
Others (see notice)

Additional information on eligibility (from the notice)

Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 5304 (formerly cited as 25 U.S.C. 450b)) is eligible to apply. See 42 CFR § 51a.3(a)). Domestic faith-based and community-based organizations are eligible to apply.

Also named in the notice's eligibility text

Nonprofits without 501(c)(3) status

Matched from the wording above by GrantsJunction — confirm in the full announcement.

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

HRSA-22-145 Notice of Funding OpportunityFull Announcement · MCHB HRSA-22-145 (UP4) HHT_Final.pdfPDF · 387 KB

Assistance Listing

What is an ALN?

93.110Special Projects of Regional and National SignificanceProgram →

Reported obligations under ALN 93.110

Historical data · not a prediction

FY24

$274M

FY25

$266M

FY26

$186M est.

Source: SAM.gov Assistance Listing 93.110. Program-wide totals, not awards from this specific opportunity.

Who was funded under ALN 93.110

Historical data · not a prediction

Since October 1, 2023, 964 grant awards had funding actions under Special Projects of Regional and National Significance, with 1,399 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.

UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER$32.2M
ZERO TO THREE NATIONAL CENTER FOR INFANTS, TODDLERS & FAMILIES$30.9M
CHILDREN'S NATIONAL MEDICAL CENTER$29.7M
AMERICAN ACADEMY OF PEDIATRICS$14.8M
MICHIGAN PUBLIC HEALTH INSTITUTE$14.4M

Recipients, states, recent awards and sub-awards →Source: USAspending.gov.

Agency contact (as published)

Health Resources and Services Administration
cnovoa@hrsa.gov
301-443-7432

Quick answers

Who is eligible to apply for “Hereditary Hemorrhagic Telangiectasia (HHT) Center”?

The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Federally recognized tribal governments, Native American tribal organizations, 501(c)(3) nonprofits, For-profit organizations (not small businesses), Small businesses and Others (see notice). Additional restrictions may apply; review the full notice.

How much funding is available through “Hereditary Hemorrhagic Telangiectasia (HHT) Center”?

Per the notice, individual awards are listed as up to $2m, total estimated program funding is $2,000,000 and the agency expects to make about 1 awards.

How do I apply for “Hereditary Hemorrhagic Telangiectasia (HHT) Center”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HRSA-22-145), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedALN 93.110